Skip to main content

IMMUNOLOGY2026™ Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Kellsye Paula Fabian, PhD

Staff Scientist
National Cancer Institute, National Institutes of Health

Poster(s):

(861) Improved natural killer cell targeting of prostate carcinoma with ATR inhibitor tuvusertib in combination with IL-15 receptor superagonist N-803

Friday, April 17, 2026
11:30 AM - 12:30 PM US ET